Division of Hematology and Oncology Vanderbilt University — Nashville, Tennessee

Division of Hematology and Oncology Vanderbilt University is a clinical research site located in Nashville, Tennessee, United States 37232.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Division of Hematology and Oncology Vanderbilt University has participated in 1 clinical trials.

Therapeutic areas: Mantle Cell Lymphoma.

Sponsors: Millennium Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Division of Hematology and Oncology Vanderbilt University?

Division of Hematology and Oncology Vanderbilt University has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Division of Hematology and Oncology Vanderbilt University conducted?

Division of Hematology and Oncology Vanderbilt University has 1 clinical trials on record. Their work covers Mantle Cell Lymphoma.

Is Division of Hematology and Oncology Vanderbilt University accredited by Crixeo Health?

Division of Hematology and Oncology Vanderbilt University has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Division of Hematology and Oncology Vanderbilt University?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.